Trajectories and Palliation Study (TAPS)

轨迹和姑息治疗研究 (TAPS)

基本信息

  • 批准号:
    8258184
  • 负责人:
  • 金额:
    $ 45.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-27 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Evidence increasingly supports the role of palliative care in improving both the efficiency of care and the quality of life of patients and caregivers living with advanced chronic serious illness. Improving access to and use of palliative care is becoming more important with our aging population and prevalence of advanced chronic illness, as well as fiscal constraints on healthcare spending. RAND Health developed the Future Elderly Model (FEM) for the Center for Medicare and Medicaid Services (CMS) to evaluate the impact of healthcare innovations on the utilization and cost of care, as well as patient and caregiver outcomes. RAND has used FEM to evaluate the future impact of changing demographics, lifestyle choices, novel technologies, and other trends for CMS. We propose to evaluate trajectories of serious chronic illness using data from the Medicare Current Beneficiary Survey (MCBS) and the Health and Retirement Survey (HRS) to characterize function, pain, emotional wellbeing over time among patients and their caregivers, comparing both prospective and retrospective approaches, and narrow and broad categorizations of cancer, organ failure, and frailty trajectories. We will evaluate a range of patient characteristics and healthcare events tha are associated with critical changes in those trajectories, in order to characterize possible triggers for implementing palliative care. We will update and expand extensive literature reviews we previously conducted for the NIH State of the Science Meeting on End of Life Care in 2004 in order to synthesize the literature on the effectiveness of palliative services including hospice in improving QOL, utilization, and cost outcomes. Informed by the literature, an expert panel will then rate the feasibility and validity of policy scenarios to implement palliative care hat address the timing, setting, and composition of palliative care services. Finally, informed by our empiric examination of trajectories, a synthesis of the literature, and ratings of the panel, we wil use the FEM to consider the impact of the highest priority policy scenarios to implement palliative care services on patients, caregivers, and Medicare utilization and cost. Our team has worked closely together conducting research on policy-relevant aspects of palliative and end of life care, and members of our team have extensive policy experience developing, implementing, and evaluating policies to improve the care of advanced serious chronic illness. We have tremendous expertise in the methods of the proposed project including quantitative analyses, literature syntheses, appropriateness panel methodologies, and policy dissemination. This project will not only inform policy, but also identify critical gaps in the understanding of trajectories and the effectiveness of palliative care to inform research priorities. PUBLIC HEALTH RELEVANCE: The overall aim of this proposal is to identify evidence-based approaches to administration of quality of life preserving services in patients with advanced disease and forecast the impact of such approaches on utilization, costs, patient and caregiver quality of life related outcomes. In particular, we are concerned with optimal timing, implementation, and composition of palliative care in consideration of decline and recovery in multiple dimensions of patients' quality of life, and the impact of policies based on this evidence on patients, their caregivers, and utilization and treatment patterns.
描述(由申请人提供):越来越多的证据支持姑息治疗在改善晚期慢性严重疾病患者和护理人员的护理效率和生活质量方面的作用。随着人口老龄化和晚期慢性病的流行,以及医疗支出的财政限制,改善姑息治疗的获得和使用变得越来越重要。兰德健康为医疗保险和医疗补助服务中心(CMS)开发了未来老年人模型(FEM),以评估医疗保健创新对护理利用和成本以及患者和护理人员结果的影响。兰德使用FEM来评估人口统计数据变化、生活方式选择、新技术和其他趋势对CMS的未来影响。 我们建议使用医疗保险当前受益调查(MCBS)和健康与退休调查(HRS)的数据来评估严重慢性疾病的轨迹,以表征患者及其护理人员随时间推移的功能,疼痛,情绪健康,比较前瞻性和回顾性方法,以及癌症,器官衰竭和虚弱轨迹的狭义和广义分类。我们将评估一系列与这些轨迹中的关键变化相关的患者特征和医疗事件,以表征实施姑息治疗的可能触发因素。 我们将更新和扩展我们以前在2004年为NIH临终关怀科学会议进行的广泛的文献综述,以综合有关姑息治疗服务有效性的文献,包括 临终关怀在改善生活质量,利用率和成本结果。根据文献,专家小组将评估政策方案的可行性和有效性,以实施姑息治疗,解决姑息治疗服务的时间,设置和组成。最后,通过我们对轨迹的经验性检查、文献的综合和小组的评级,我们将使用FEM来考虑最优先的政策方案对患者、护理人员和医疗保险利用率和成本的影响。 我们的团队密切合作,对姑息治疗和临终关怀的政策相关方面进行研究,我们团队的成员在制定,实施和评估改善晚期严重慢性病护理的政策方面拥有丰富的政策经验。我们在拟议项目的方法方面拥有丰富的专业知识,包括定量分析,文献综合,适当性小组方法和政策传播。该项目不仅将为政策提供信息,而且还将确定在理解轨迹和姑息治疗有效性方面的关键差距,以告知研究优先事项。 公共卫生关系:本提案的总体目标是确定晚期疾病患者生命质量维持服务管理的循证方法,并预测这些方法对利用率、成本、患者和护理人员生活质量相关结局的影响。特别是,我们关注的是最佳时机,实施和姑息治疗的组成,考虑到患者生活质量的多个方面的下降和恢复,以及基于这些证据的政策的影响 对患者、其护理人员以及利用和治疗模式的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl Lorenz其他文献

Karl Lorenz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl Lorenz', 18)}}的其他基金

Improving Palliative Measurement Application with Computer-Assisted-Abstraction Study
通过计算机辅助抽象研究改进姑息测量应用
  • 批准号:
    10305693
  • 财政年份:
    2018
  • 资助金额:
    $ 45.08万
  • 项目类别:
Improving Palliative Measurement Application with Computer-Assisted-Abstraction Study
通过计算机辅助抽象研究改进姑息测量应用
  • 批准号:
    10216351
  • 财政年份:
    2018
  • 资助金额:
    $ 45.08万
  • 项目类别:
Effective Screening for Pain Study
疼痛研究的有效筛查
  • 批准号:
    8397641
  • 财政年份:
    2013
  • 资助金额:
    $ 45.08万
  • 项目类别:
Trajectories and Palliation Study (TAPS)
轨迹和姑息治疗研究 (TAPS)
  • 批准号:
    8339365
  • 财政年份:
    2011
  • 资助金额:
    $ 45.08万
  • 项目类别:
Trajectories and Palliation Study (TAPS)
轨迹和姑息治疗研究 (TAPS)
  • 批准号:
    8735667
  • 财政年份:
    2011
  • 资助金额:
    $ 45.08万
  • 项目类别:
Trajectories and Palliation Study (TAPS)
轨迹和姑息治疗研究 (TAPS)
  • 批准号:
    8538264
  • 财政年份:
    2011
  • 资助金额:
    $ 45.08万
  • 项目类别:
VA ASSIST Project
VA 协助项目
  • 批准号:
    8182131
  • 财政年份:
    2010
  • 资助金额:
    $ 45.08万
  • 项目类别:
VA ASSIST Project
VA 协助项目
  • 批准号:
    7867852
  • 财政年份:
    2010
  • 资助金额:
    $ 45.08万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 45.08万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了